Neil Desai, MD
Radiation Oncology · Dallas, TXNPI 1366758237
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,496 of the $29,401 with a category attached, or 62.9%. Boston Scientific accounts for 71.1% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2021 at $9,250 and has fallen 88.4% since, to $1,071 in 2025. Among radiation oncology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $260.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$21K
- Telix Pharmaceuticals$3K
- Novartis$2K
- Pfizer$420
- AstraZeneca$358
- Johnson & Johnson$355
- plus $2K from 19 others
Across 44 payments — averaging $195,188 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bayer$7.9M
- Augmenix, Inc.$354K
- Boston Scientific$223K
- Pfizer$113K
- Reflexion Medical, Inc.$33K
What the payments were for
- Consulting fees$18,49663%
- Speaking & faculty fees$3,25511%
- Travel & lodging$1,6986%
- Food & beverage$5,95220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 50 | $20,907 |
| Telix Pharmaceuticals | 5 | $3,122 |
| Novartis | 2 | $2,108 |
| Pfizer | 5 | $420 |
| AstraZeneca | 4 | $358 |
| Johnson & Johnson | 3 | $355 |
| Inari Medical, Inc. | 10 | $327 |
| Blue Earth Diagnostics | 3 | $303 |
| Elekta, Inc. | 1 | $184 |
| Taiho Oncology, Inc. | 5 | $179 |
| Immunitybio, Inc. | 1 | $150 |
| Abbott | 1 | $132 |
| Spinal Simplicity, LLC | 5 | $124 |
| Exelixis Inc. | 1 | $107 |
| Argon Medical Devices, Inc. | 7 | $107 |
| Accuray Incorporated | 1 | $97 |
| Profound Medical Corp. | 1 | $75 |
| Angiodynamics, Inc. | 1 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $64 |
| Progenics Pharmaceuticals, Inc. | 1 | $61 |
| Imperative Care, Inc | 1 | $36 |
| Shockwave Medical, Inc | 1 | $35 |
| Smith+Nephew | 1 | $30 |
| KARL Storz Endoscopy-america | 1 | $25 |
| Teleflex LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPACEOAR VUE$8,228
- GENERAL BPH$4,900
- ILLUCCIX$4,562
- SpaceOAR VUE System - 10mL$2,158
- SPACEOAR$1,138
- Erleada$355
- Axumin$274
- GENERAL ONCOLOGY$273
- ELEKTA UNITY$184
- ANKTIVA$150
- Balversa$150
- SpaceOAR System$132
- ESPRIT$132
- ORGOVYX$129
- LYNPARZA$117
- Cabometyx$107
- GENERAL - THERAPIES$107
- TECVAYLI$102
- TALVEY$102
- RYBREVANT$102
How this compares
$29,401 in reported general payments places this provider in the 95th percentile of 418 radiation oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 58 | $147,980 |
| Estradiol (Once Weekly)Estradiol | 21 | $1,316 |
| Tamsulosin Hcl | 83 | $1,243 |
| Bicalutamide | 22 | $478 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 15 | $188 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Dallas
- Hak ChoyDallas$119K
- Robert TimmermanDallas$77K
- Puneeth IyengarDallas$60K
- Assal RahimiDallas$43K
- Kiran KumarDallas$29K
- Kenneth WestoverDallas$24K
- Jonathan VermaDallas$6K
- James WelshHouston$421K
- Stephen ChunHouston$344K
- Jim HsiangCorpus Christi$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.